The Care Quality Commission
  • Doctor
  • GP practice

Frimley Green Medical Centre

Overall: Good read more about inspection ratings

1 Beech Road, Frimley Green, Camberley, Surrey, GU16 6QQ (01252) 835016

Provided and run by:
Bartlett Group Practice

All Inspections

6 July 2023

During a monthly review of our data

We carried out a review of the data available to us about Frimley Green Medical Centre on 6 July 2023. We have not found evidence that we need to carry out an inspection or reassess our rating at this stage.

This could change at any time if we receive new information. We will continue to monitor data about this service.

If you have concerns about Frimley Green Medical Centre, you can give feedback on this service.

16 November 2019

During an annual regulatory review

We reviewed the information available to us about Frimley Green Medical Centre on 16 November 2019. We did not find evidence of significant changes to the quality of service being provided since the last inspection. As a result, we decided not to inspect the surgery at this time. We will continue to monitor this information about this service throughout the year and may inspect the surgery when we see evidence of potential changes.

16 March 2017

During an inspection looking at part of the service

Letter from the Chief Inspector of General Practice


We carried out an announced comprehensive inspection at Dr Cureton and Partners on 9 September 2016. The overall rating for the practice was good. However, during this inspection we found breaches of legal requirements and the provider was rated as requires improvement under the safe domain. The full comprehensive report for the September 2016 inspection can be found by selecting the ‘all reports’ link for Dr Cureton and Partners on our website at www.cqc.org.uk.

Following this inspection the practice sent to us an action plan detailing what they would do to meet the legal requirements in relation to the following:-

  • Ensuring that controlled drugs used within the practice were stored securely in line with national guidance.
  • Ensuring that all significant events within the practice were reported and recorded and that all staff were involved in discussions and reviews to improve practice.

This inspection was an announced focused inspection carried out on 16 March 2017. This was to confirm that the practice had carried out their plan to meet the legal requirements in relation to the breaches in regulations that we identified in our previous inspection on 9 September 2016. This focused inspection has determined that the provider is now meeting all requirements and is now rated as good under the safe domain. This report covers our findings in relation to those requirements and also additional improvements made since our last inspection.

Our key findings were as follows:

  • The practice had reviewed security measures in place for controlled drugs. We saw evidence that only authorised staff had access to controlled drugs and that keys to the controlled drugs safe within the dispensary were stored securely in a separate key safe.
  • The practice had ensured that all staff were included in the review of and learning from significant events where relevant to their role. Significant events were recorded centrally with detailed information being available for all staff to review including full details of the incident, areas of concern, suggestions for doing things differently in the future and action points.

In addition we saw evidence of:

  • New meeting structures in place for clinical and non clinical staff. Staff we spoke with told us the new meeting structure supported good communication and allowed them the opportunity to be involved in formal discussions about the practice.
  • Controlled drugs being monitored in line with best practice guidance. This included dispensing staff regularly recording stock movement and the balance of drugs stored, a monthly stock check and a six monthly audit. We also saw that standard operating procedures had been updated.


Professor Steve Field (CBE FRCP FFPH FRCGP) 

Chief Inspector of General Practice

9 September 2016

During a routine inspection

Letter from the Chief Inspector of General Practice

We carried out an announced comprehensive inspection at Dr Cureton and Partners on 9 September 2016. Overall the practice is rated as good.

Our key findings across all the areas we inspected were as follows:

  • Staff assessed patients’ needs and delivered care in line with current evidence based guidance. Staff had been trained to provide them with the skills, knowledge and experience to deliver effective care and treatment.
  • Patients said they were treated with compassion, dignity and respect and they were involved in their care and decisions about their treatment.
  • Information about services and how to complain was available and easy to understand. Improvements were made to the quality of care as a result of complaints and concerns.
  • Patients said they found it easy to make an appointment with a named GP and there was continuity of care, with urgent appointments available the same day.
  • The practice had good facilities and was well equipped to treat patients and meet their needs.
  • The provider was aware of and complied with the requirements of the duty of candour.
  • There was an open and transparent approach to safety and a system in place for reporting and recording significant events, however not all staff felt involved in the process of review and not all incidents were properly recorded within the practice.
  • Risks to patients were generally assessed and well managed, however the storage and monitoring of controlled drugs within the treatment room and storage of the controlled drug key within the dispensary was unsafe.
  • There was a clear leadership structure and staff felt supported by management. However, not all staff felt actively involved in discussions about the practice.

The areas where the provider must make improvement are:

  • Ensure that controlled drugs used within the practice are stored securely in line with national guidance.
  • Ensure that all significant events within the practice are reported and recorded and that all staff are involved in discussions and reviews to improve practice.

In addition, the areas where the provider should make improvements are:

  • Ensure that staff feel involved in formal discussions about the practice and that meeting structures support good communication, particularly between GPs and nursing staff and that other staff have the opportunity to attend regular meetings.
  • Ensure that controlled drugs used within the practice are monitored in line with best practice guidance.

Professor Steve Field (CBE FRCP FFPH FRCGP) 

Chief Inspector of General Practice